This activity already occurred and is no longer available.
Multimodality Molecular Imaging of Prostate Cancer Symposium - Part II
Multimodality Molecular Imaging of Prostate Cancer Symposium - Part II
Multimodality Molecular Imaging of Prostate Cancer Symposium - Part II

Authors
Jorge A. Carrasquillo, MD, is a researcher for Algeta, a researcher for Chugai, a researcher for Genetech, a researcher for Molecular Insight Pharmaceutical, and a researcher for Wilex.

Donald A. Podloff, MD, is a consultant and researcher for GE Healthcare.

Martin G. Pomper, MD, PhD, is a consultant for BIND Biosciences, and a SAB member for Molecular Insight Pharmaceuticals.

Anna M. Wu, PhD, is a board member of ImaginAb.

Peter J. Choyke, MD, is a researcher for GE Healthcare, a researcher for Philips Healthcare, and a researcher for Siemens.

John W. Babich, PhD, is a director and investor in Molecular Insight.

Steven M. Larson, MD, is a consultant for Amgen, a consultant for Cougar Biotech, a consultant for ImaginAb, a consultant for Millenium, and a consultant for Perceptive Informatics.


Target Audience
Physicians, pharmacists, and technologists.

Objectives
At the completion of this activity, the participant will be able to:
1. Educate the molecular imaging community about the latest advances and state-of-the-art in imaging patients with prostate cancer.
2. Promote basic science research in molecular imaging and clinical applications for prostate cancer.
3. Foster potential collaborations among scientists and clinicians working in various related fields as they relate to prostate cancer.

Continuing Education Credit Information


AMA-PRA (Physician)
The Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

SNMMI designates this enduring material for a maximum of 4.0 AMA PRA Category 1 CreditTM. Physicians should claim only credit commensurate with the extent of their participation in the activity. To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation. Release date: 10/12/12 Expiration date: 10/12/15.

   

ACPE (Pharmacists)

The Society for Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been designated as knowledge-based CPE. The universal program number for this enduring material is 0210-0000-12-401-H04-P. Total available credit for pharmacists is 4.0 hours or 0.40 CEUs. Release date: 10/12/12 Expiration date: 10/12/15. To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation.

VOICE (Technologists)
The SNMMI, through its Verification of Involvement in Continuing Education (VOICE) program, has approved this journal article for a maximum of 3.25 continuing education hours (CEHs). VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A credit. In order to receive CE credit, you must first complete the activity content. When completed, take the post-test assessment.  You must obtain a score of 80% to receive the CE credit.  You will have no more than 3 attempts to successfully complete the post-test. Release date: 10/12/12 Expiration date: 10/12/15. California Scope: 3.25 Imaging(I)/Non-Imaging(NI) / Radiopharmacy(R) / Therapy(T).

Minimum system requirements

Supported Internet Browsers:
- Microsoft Internet Explorer (version 7 or higher)
- Google Chrome (latest version)
- Mozilla Firefox (latest version)
- Apple Safari (version 4 or higher)

Plug-in: Adobe Acrobat Reader (http://get.adobe.com/reader/)

For questions please contact the Education Department 703-708-9000.
© 2013 SNMMI. All rights reserved.   

For more information on our privacy policy, please click the link below.




Type:     Internet Activity (Enduring Material)
19 Registered Users